Tumor-cell number and viability as quality and efficacy parameters of autologous virus-modified cancer vaccines in patients with breast or ovarian cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/9193327

Download in:

View as

General Info

PMID
9193327